We maybe have finished movement inside this monthly downward channel, which looks like a corrective channel for previous bullish impulse. Chances are we will go north from here. But if price will brake this channel downwards it may as well become ugly, and there is no support levels, I guess?
Anyway, now GILD highly tightened to SNP and thus electional uncertainty.
News looks positive for this company to produce a new vaccine for the UK, if proved safe would go global. A sound investment opportunity.
Can see it rising today.
So they had a death on the vaccine research and look to be forming a head and shoulder pattern which is typical of a reversal in price, how come the news always comes so in time? the markets are so fascinating.
The pharmaceutical sector is one of the most interesting ones in such a troubled period.
I see some growth potential for $ACAD in the short term. It is showing a positive trend that is already consolidated and heading for a possible TP of around 44-45$
I see this level as an important resistance since it has been tested repeatedly in the past.
***As usual, not...
CLOVIS maker of FDA approved Rubraca® which is a treatment of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer whose cancer has come back and who are in response (complete or partial response) to a platinum-based chemotherapy. www.rubraca.com
Sitting at a pretty interesting area right now, sure it will get some more movement soon as we are...
RSI Divergence on Daily Chart
Window / Gap from Rs.2784 to Rs.3063
Considering Stock has closed around Rs.3050 for 2 consecutive day, any fall from hereon would cause the stock the to fall to Rs.2784 levels.
Suggestion: Sell a Call at CMP 3050 / 3000 with a SL Rs.3120.
Anticipating some positive news from RLFTF's and further FDA approval for it's Aviptadil.
ABCDE Triagle wave approaching completion, confirmed by Williams Alligator, and Fib Retracement
A bounced off 0.382 level
C bounced off 0.5 level
Look for E confirmation off 0.618 level
Should price exit the triangle formation, setting target @ $1.2
Glenmark at Crucial Support of 459, if breaks, then can test 418, if consolidates at 459-465 then can give move up to 540 by 20th September 2020. Wait and watch if 459-456 levels are respected.
Breaking down through support, this is what kept me out of trading PFE to the long-side even though it looked bullish. With the elections coming up and democrats leading the polls, I'd stay away from pharma and insurers. Lean towards medical devices if you need healthcare exposure.
![VLA: VLA [LONG] Covid Cash](https://s3.tradingview.com/b/bl5e86iu_mid.png "VLA [LONG] Covid Cash")
